A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects
Clinical trial NCT03776240 · COMPLETED
Trial details
- NCT number
- NCT03776240
- Sponsor
- Prestige Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2019-08-19
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.